CRISPR Craze to Transform Cardiac Biology: Trends in Molecular Medicine
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer: Trends in Molecular Medicine
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome | Nature Medicine
/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening | Nature Protocols
The kill-switch for CRISPR that could make gene-editing safer
How CRISPR Is Changing Cancer Research and Treatment - National Cancer Institute
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
Nature Collections: CRISPR-Cas9 Genome Editing - Scientific American
In utero CRISPR-mediated therapeutic editing of metabolic genes | Nature Medicine
The Dark Side of CRISPR - Scientific American
CRISPR: the movie
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology
Controlling and enhancing CRISPR systems | Nature Chemical Biology
Frontiers | Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9 | Plant Science
CRISPR gene editing - Wikipedia
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJM
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
